WAYLAND, Mass., July 18, 2016 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, announces the U.S. Food and Drug Administration (FDA) clearance of its non-invasive fat destruction device, UltraShape Power™. The FDA clearance is for non-invasive reduction of abdominal circumference via fat cell destruction.
UltraShape Power uses focused, pulsed mechanical ultrasound energy to target and destroy fat, offering measurable fat reduction to the abdominal area. UltraShape Power's advanced USculpt transducer delivers 20% more energy than its predecessor. A recent clinical study with UltraShape Power's USculpt transducer documents a 32% reduction in subcutaneous fat thickness, positioning UltraShape Power as a powerful solution for non-invasive fat reduction.
 
Continue reading at PR Newswire.
 
 
 
Register Today! A Step-By-Step Guide to Building a Profitable Medical Spa - San Jose, CA: September 19-20, 2016 
A Step-By-Step Guide to Building a Profitable Medical Spa - Dallas, Texas: November 6-7, 2016
Arizona Medical Spa and Medical Aesthetics Regulatory Workshop - Scottsdale, AZ: December 5, 2016